Your browser doesn't support javascript.
loading
Development of Lanzyme as the Potential Enzyme Replacement Therapy Drug for Fabry Disease.
Deng, Mulan; Zhou, Hongyu; Liang, Zhicheng; Li, Zhaoyang; Wang, Yanping; Guo, Wanyi; Zhao, April Yuanyi; Li, Fanghong; Mu, Yunping; Zhao, Allan Zijian.
Afiliación
  • Deng M; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Zhou H; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Liang Z; The School of Medicine, South China University of Technology, Guangzhou 510000, China.
  • Li Z; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Wang Y; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Guo W; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Zhao AY; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Li F; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Mu Y; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
  • Zhao AZ; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510000, China.
Biomolecules ; 13(1)2022 Dec 27.
Article en En | MEDLINE | ID: mdl-36671438
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Proteínas Recombinantes / Enfermedad de Fabry / Alfa-Galactosidasa / Terapia de Reemplazo Enzimático Límite: Animals Idioma: En Revista: Biomolecules Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Proteínas Recombinantes / Enfermedad de Fabry / Alfa-Galactosidasa / Terapia de Reemplazo Enzimático Límite: Animals Idioma: En Revista: Biomolecules Año: 2022 Tipo del documento: Article País de afiliación: China